Your browser doesn't support javascript.
loading
Improving clinical benefit for prostate cancer patients through the combination of androgen deprivation and immunotherapy.
Kwilas, Anna R; Gameiro, Sofia R; Kim, Peter S; Malamas, Anthony S; Hodge, James W.
Afiliación
  • Kwilas AR; Laboratory of Tumor Immunology and Biology; Center for Cancer Research; National Cancer Institute; National Institutes of Health ; Bethesda, MD, USA.
  • Gameiro SR; Laboratory of Tumor Immunology and Biology; Center for Cancer Research; National Cancer Institute; National Institutes of Health ; Bethesda, MD, USA.
  • Kim PS; Laboratory of Tumor Immunology and Biology; Center for Cancer Research; National Cancer Institute; National Institutes of Health ; Bethesda, MD, USA.
  • Malamas AS; Laboratory of Tumor Immunology and Biology; Center for Cancer Research; National Cancer Institute; National Institutes of Health ; Bethesda, MD, USA.
  • Hodge JW; Laboratory of Tumor Immunology and Biology; Center for Cancer Research; National Cancer Institute; National Institutes of Health ; Bethesda, MD, USA.
Oncoimmunology ; 4(6): e1009303, 2015 Jun.
Article en En | MEDLINE | ID: mdl-26155431
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Oncoimmunology Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Oncoimmunology Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos